Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays. (Q40206862)
Jump to navigation
Jump to search
scientific article published on 7 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays. |
scientific article published on 7 November 2006 |
Statements
Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays (English)
Glenn Noronha
Kathy Barrett
Antonio Boccia
Tessa Brodhag
Jianguo Cao
Chun P Chow
Elena Dneprovskaia
John Doukas
Richard Fine
Xianchang Gong
Colleen Gritzen
Hong Gu
Ehab Hanna
John D Hood
Steven Hu
Xinshan Kang
Jann Key
Boris Klebansky
Ahmed Kousba
Ge Li
Dan Lohse
Chi Ching Mak
Moorthy S S Palanki
Ved P Pathak
Joel Renick
Feng Shi
Richard Soll
Ute Splittgerber
Silva Stoughton
Suhan Tang
Shiyin Yee
Binqi Zeng
Ningning Zhao
7 November 2006